Department of Biostatistics and Translational Medicine
Author : Jędrzej Chrzanowski
Dr. Konrad Stawiski has been elected as a member of the international working group focusing on artificial intelligence in oncological radiotherapy within the European Society for Radiotherapy and Oncology. Dr. Konrad Stawiski’s term will last for 3 years. The task of the working groups is to assist in developing clinical and technical guidelines, provide advice […]
In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]
We are pleased to announce the recent grant success of our team! In the November results of the National Science Centre grant program OPUS 25, we have secured funding for the project “Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer”. The project was scored as the 2nd […]
We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from our team, titled “B cell depletion therapy to improve outcomes of steroid-sensitive nephrotic syndrome in adults – the BOOSTER trial,” has received funding recommendation in the second edition of the Medical Research Agency’s Head-to-Head Research […]
We are pleased to announce that Prof. Wojciech Fendler has been elected as a member of the Scientific Committees of the Polish Academy of Sciences in the Committee on Clinical Sciences and the Committee on Human Genetics and Molecular Pathology. Congratulations! More information and full lists of the Committees’ composition are available here.
Despite significant progress in oncology in recent decades, only about 50% of patients with invasive bladder cancer (MIBC) affecting the muscle layer, survive five years after diagnosis. New hope comes from the combination of radiochemotherapy with the rapidly advancing field of immunotherapy. A member of our team, and a specialist in oncological radiotherapy from the […]
We cordially invite applications from young ambitious scientists for the project “Identification of Angiogenesis and Metabolic Markers in Endometriosis and its Associated Ovarian Epithelial Cancer using Photoacoustic Imaging and Data Exploration (ENDOVO),” under the supervision of Dr. Monika Golińska, funded by the POLONEZ BIS 3 program of the National Science Centre for the years 2023-2025. […]
Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% of new cancer diagnoses worldwide. Approximately 5% – 10% of cases involve hereditary breast and ovarian cancer (HBOC), most commonly linked to mutations in the BRCA1 or BRCA2 genes. Currently, BRCA1/2 genetic tests are recommended […]
We are happy to inform about our team member, Dr. Bartłomiej Tomasik, tremendous achievement – the co-discovery of a new DNA repair mechanism. Dr. Bartłomiej Tomasik is a co-author of the article that describes the newly discovered mechanism for repairing double-strand DNA breaks. The work has been published in the prestigious journal ‘Nature Structural & […]
On August 24, 2023, Professor Anna Woźniacka, the Director of the International Doctoral School, and Professor Lucyna Woźniak, the Vice-Rector for Science and International Cooperation, presented awards to the doctoral students of the International Doctoral School who were honoured during the Public Reporting Session. Among the awarded students were members of our team: The awardees […]
